VCEL compared with TGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

VCELVericel Corp

Mkt capRevenueRevenue

TGTXTG Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VCELVericel Corp

TGTXTG Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VCEL

0 of 3at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26—▲+13.85%—

Jul 30 '26±13.2%▲+2.12%×0.16

May 7 '26±9.1%▼−4.49%×0.49

Feb 26 '26±14.8%▲+1.59%×0.11

TGTX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 3 '26±11.4%▼−11.26%×0.99

May 6 '26±8.7%▲+16.26%×1.87

= impliedVCEL realized, solidTGTX realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Feb 26 '26

±9.3%

▲+4.18%

×0.45

Nov 3 '25±14.9%▼−3.13%×0.21

VCELVericel Corp

54.46▲+5.18%· post 55.10

Mkt cap$2.8BRevenue$85MQ3 FY26Revenue$276MFY25

TGTXTG Therapeutics, Inc.

59.76▲+3.07%· post 59.85

ClosedNov 6 '26

Mkt cap$9.2BRevenue$240MQ2 FY26Revenue$616MFY25

Compare

ClosedNov 6 '26

VCELVericel Corp

TGTXTG Therapeutics, Inc.

54.46▲+5.18%post 55.10

Price

59.76▲+3.07%post 59.85

$2.8B

Mkt cap

$9.2B

Q3 FY26$85M

Revenue

$240MQ2 FY26

FY25$276M

Revenue

$616MFY25

VCEL54.46▲+5.18%vsTGTX59.76▲+3.07%ClosedNov 6 '26